JPMorgan Life Sciences Private Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 4

Professionals

  • Investments
  • 12

  • Portfolio
  • 11

  • Exits
  • 2

Exits

JPMorgan Life Sciences Private Capital General Information

Company Description

Founded in 2022, JPMorgan Life Sciences Private Capital is a venture capital investment firm based in New York. The firm is an investment arm of JP Morgan and seeks to invest in both early and growth-stage healthcare companies. The firm focuses on genetic medicine, oncology, neurodegenerative diseases, rare diseases, autoimmunity, artificial intelligence and machine learning platforms, metabolic diseases, and neuropsychology.

Business Details

Year Founded
2022
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Corporate Office
  • New York, NY
  • United States

JPMorgan Life Sciences Private Capital Investments (12)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
GT Metabolic 28-Oct-2026 Later Stage VC Surgical Devices Generating Revenue
Korsana Biosciences 07-Sep-2026 Drug Discovery Pre-Clinical Trials
Averna Therapeutics 19-Mar-2026 Pharmaceuticals Generating Revenue
Turbett Surgical 27-Jan-2026 Other Devices and Supplies Generating Revenue
Korsana Biosciences 01-Sep-2025 Drug Discovery Pre-Clinical Trials
ABK Biomedical 09-May-2025 Surgical Devices Pre-Clinical Trials
Biolog 10-Feb-2025 Other Pharmaceuticals and Biotechnology Generating Revenue
Ottimo Pharma 19-Dec-2024 Drug Discovery Generating Revenue
Pathalys Pharma 07-Aug-2024 Early Stage VC Drug Discovery Clinical Trials - Phase 3
Enlaza Therapeutics 30-Apr-2024 Early Stage VC Drug Discovery Generating Revenue
You’re viewing 10 of 12 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

JPMorgan Life Sciences Private Capital Exits (2)

Company Name Exit Date Exit Type Exit Size
Achieve Life Sciences 29-Feb-2024
You’re viewing 1 of 2 exits. Get the full list »

JPMorgan Life Sciences Private Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

JPMorgan Life Sciences Private Capital Co-Investors (40)

Name With Exits Lead Partner Series Industry
Samsara BioCapital 3 Series chart Industry bar
Invus (Private Equity) Series chart Industry bar
JP Morgan Asset Management Series chart Industry bar
Janus Henderson Investors Series chart Industry bar
OrbiMed Series chart Industry bar
You’re viewing 5 of 40 co-investors. Get the full list »

JPMorgan Life Sciences Private Capital FAQs

  • What is JPMorgan Life Sciences Private Capital?

    Founded in 2022, JPMorgan Life Sciences Private Capital is a venture capital investment firm based in New York.

  • When was JPMorgan Life Sciences Private Capital founded?

    JPMorgan Life Sciences Private Capital was founded in 2022.

  • Where is JPMorgan Life Sciences Private Capital headquartered?

    JPMorgan Life Sciences Private Capital is headquartered in New York, NY.

  • What is JPMorgan Life Sciences Private Capital's total asset value?

    JPMorgan Life Sciences Private Capital has around in total assets under management.

  • How many investments has JPMorgan Life Sciences Private Capital made?

    JPMorgan Life Sciences Private Capital has made 12 investments.

  • What has JPMorgan Life Sciences Private Capital invested in?

    JPMorgan Life Sciences Private Capital has made numerous investments in companies like GT Metabolic, Korsana Biosciences, and Averna Therapeutics within the Surgical Devices, Drug Discovery, and Pharmaceuticals industries.

  • What has JPMorgan Life Sciences Private Capital invested in recently?

    JPMorgan Life Sciences Private Capital's latest investment was on 28-Oct-2026 in GT Metabolic, a company within the Surgical Devices industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process